NeuPath Health Inc.
NPTH.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 87.38% | -9.00% | 38.44% | -952.21% | -153.52% |
| Total Depreciation and Amortization | -2.90% | -2.24% | -7.99% | -9.34% | -12.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.72% | 1.24% | 2.30% | 548.12% | 1,347.19% |
| Change in Net Operating Assets | -170.66% | 3,223.05% | 161.88% | 8.61% | 46.68% |
| Cash from Operations | -37.43% | 50.43% | 23.70% | 0.02% | 21.43% |
| Capital Expenditure | 7.82% | 24.72% | -9.24% | 5.66% | -242.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -99.21% | -99.21% |
| Cash Acquisitions | -- | -- | 100.00% | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -9.42% | 22.87% | 12.19% | -155.51% | -159.28% |
| Total Debt Issued | -100.00% | -- | 25,800.00% | -- | 597.42% |
| Total Debt Repaid | 72.48% | -326.19% | -270.77% | -123.29% | -97.67% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -406.17% | -1,612.50% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -166.02% | -150.00% | 32.92% | 14.52% | -56.72% |
| Cash from Financing | -105.62% | 10.02% | 27.13% | 69.13% | 59.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -148.09% | 675.62% | 1,483.76% | 126.03% | -7.18% |